SARS-CoV-2 RBD (JN.1) ELISA Kit
PRINCIPLE OF THE ASSAY This assay employs the quantitative sandwich enzyme immunoassay technique. An antibody specific for SARS-CoV-2 RBD (JN.1) has been pre-coated onto a microplate. Standards or samples are pipetted into the wells and any SARS-CoV-2 RBD (JN.1) present is bound by the immobilized antibody. After washing away any unbound substances, a biotin-labeled antibody specific for SARS-CoV-2 RBD (JN.1) is added to the wells. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of SARS-CoV-2 RBD (JN.1) bound in the initial step. The color development is stopped and the intensity of the color is measured.
Product Specifications
Applications
Used for the quantitative determination of SARS-CoV-2 RBD (JN.1) concentration in serum and plasma.
Stability
Shipping Conditions
2-8 °C
Notes
For Research Use Only.
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TAB1, phosphorylated (Ser423) (TGF-beta-activated Kinase 1 and MAP3K7-binding Protein 1, TGF-beta-activated Kinase 1-binding Protein 1, TAK1-binding Protein 1, 3'-Tab1, Mitogen-activated Protein Kinase Kinase Kinase 7-interacting Protein 1, MAP3K7IP1) (PE) discontinued
N'2- (2,3,3-trichloroacryloyl) -4-methyl-3- (1H-pyrrol-1-yl) thiophene-2-carbohydrazide
Recombinant Mouse Neurotrophin receptor-interacting factor 2 (Nrif2) , partial